Main Logo
+17162654855
[email protected]

Exploring Innovation in Pharmacovigilance Outsourcing Market Industry

Pharmacovigilance Outsourcing Market by Service (Pre-marketing Services, Post-marketing Services), by Therapeutic Area (Neurology, Cardiology, Oncology, Others (Respiratory and Orthopedic)), by Provider (Contract Research Organizations (CROs), Business Processing Outsourcing (BPO)), by End User (Pharmaceutical Companies, Biopharmaceutical Companies, Medical Device Companies), by North America (United States, Canada, Mexico), by Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe), by Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), by Middle East and Africa (GCC, South Africa, Rest of Middle East and Africa), by South America (Brazil, Argentina, Rest of South America) Forecast 2026-2034

Base Year: 2025
234 Pages
Main Logo

Exploring Innovation in Pharmacovigilance Outsourcing Market Industry

About Precision Market View

Precision Market View offers precise market research, industry intelligence, and data analysis for healthcare, manufacturing, technology, and energy. Our reports provide the clarity you need to make informed decisions and drive growth.

Our team combines primary research, advanced analytics, and industry expertise to deliver actionable intelligence. We offer syndicated reports, custom research, and consulting services tailored to your business needs.

At Precision Market View, we are committed to quality, transparency, and client satisfaction. Every report is rigorously validated to ensure accuracy and relevance. Our global perspective and local expertise help you understand both the big picture and the finer details of your market.

Stay informed with Precision Market View. Subscribe to our newsletter for the latest updates and research highlights, and follow us on social media for real-time insights.

Precision Market View – Clarity for Your Strategic Decisions.

Geographic Coverage of Pharmacovigilance Outsourcing Market

Higher Coverage
Lower Coverage
No Coverage

Pharmacovigilance Outsourcing Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 15.80% from 2020-2034
Segmentation
    • By Service
      • Pre-marketing Services
        • Clinical Pharmacovigilance Services
        • Case Processing Services
        • Safety Data Management Services
        • Medical Review
      • Post-marketing Services
        • Knowledge Process Outsourcing Services
        • IT Solutions and Services
    • By Therapeutic Area
      • Neurology
      • Cardiology
      • Oncology
      • Others (Respiratory and Orthopedic)
    • By Provider
      • Contract Research Organizations (CROs)
      • Business Processing Outsourcing (BPO)
    • By End User
      • Pharmaceutical Companies
      • Biopharmaceutical Companies
      • Medical Device Companies
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Market Snapshot
  3. 3. Market Dynamics
    • 3.1. Market Drivers
    • 3.2. Market Restrains
    • 3.3. Market Trends
    • 3.4. Market Opportunities
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
      • 4.1.1. Bargaining Power of Suppliers
      • 4.1.2. Bargaining Power of Buyers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
    • 4.2. PESTEL analysis
    • 4.3. BCG Analysis
      • 4.3.1. Stars (High Growth, High Market Share)
      • 4.3.2. Cash Cows (Low Growth, High Market Share)
      • 4.3.3. Question Mark (High Growth, Low Market Share)
      • 4.3.4. Dogs (Low Growth, Low Market Share)
    • 4.4. Ansoff Matrix Analysis
    • 4.5. Supply Chain Analysis
    • 4.6. Regulatory Landscape
    • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
    • 4.8. PMV Analyst Note
  5. 5. Market Analysis, Insights and Forecast 2021-2033
    • 5.1. Market Analysis, Insights and Forecast - by Service
      • 5.1.1. Pre-marketing Services
        • 5.1.1.1. Clinical Pharmacovigilance Services
        • 5.1.1.2. Case Processing Services
        • 5.1.1.3. Safety Data Management Services
        • 5.1.1.4. Medical Review
      • 5.1.2. Post-marketing Services
        • 5.1.2.1. Knowledge Process Outsourcing Services
        • 5.1.2.2. IT Solutions and Services
    • 5.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 5.2.1. Neurology
      • 5.2.2. Cardiology
      • 5.2.3. Oncology
      • 5.2.4. Others (Respiratory and Orthopedic)
    • 5.3. Market Analysis, Insights and Forecast - by Provider
      • 5.3.1. Contract Research Organizations (CROs)
      • 5.3.2. Business Processing Outsourcing (BPO)
    • 5.4. Market Analysis, Insights and Forecast - by End User
      • 5.4.1. Pharmaceutical Companies
      • 5.4.2. Biopharmaceutical Companies
      • 5.4.3. Medical Device Companies
    • 5.5. Market Analysis, Insights and Forecast - by Region
      • 5.5.1. North America
      • 5.5.2. Europe
      • 5.5.3. Asia Pacific
      • 5.5.4. Middle East and Africa
      • 5.5.5. South America
  6. 6. Global Pharmacovigilance Outsourcing Market Analysis, Insights and Forecast, 2021-2033
    • 6.1. Market Analysis, Insights and Forecast - by Service
      • 6.1.1. Pre-marketing Services
        • 6.1.1.1. Clinical Pharmacovigilance Services
        • 6.1.1.2. Case Processing Services
        • 6.1.1.3. Safety Data Management Services
        • 6.1.1.4. Medical Review
      • 6.1.2. Post-marketing Services
        • 6.1.2.1. Knowledge Process Outsourcing Services
        • 6.1.2.2. IT Solutions and Services
    • 6.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 6.2.1. Neurology
      • 6.2.2. Cardiology
      • 6.2.3. Oncology
      • 6.2.4. Others (Respiratory and Orthopedic)
    • 6.3. Market Analysis, Insights and Forecast - by Provider
      • 6.3.1. Contract Research Organizations (CROs)
      • 6.3.2. Business Processing Outsourcing (BPO)
    • 6.4. Market Analysis, Insights and Forecast - by End User
      • 6.4.1. Pharmaceutical Companies
      • 6.4.2. Biopharmaceutical Companies
      • 6.4.3. Medical Device Companies
  7. 7. North America Pharmacovigilance Outsourcing Market Analysis, Insights and Forecast, 2020-2032
    • 7.1. Market Analysis, Insights and Forecast - by Service
      • 7.1.1. Pre-marketing Services
        • 7.1.1.1. Clinical Pharmacovigilance Services
        • 7.1.1.2. Case Processing Services
        • 7.1.1.3. Safety Data Management Services
        • 7.1.1.4. Medical Review
      • 7.1.2. Post-marketing Services
        • 7.1.2.1. Knowledge Process Outsourcing Services
        • 7.1.2.2. IT Solutions and Services
    • 7.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 7.2.1. Neurology
      • 7.2.2. Cardiology
      • 7.2.3. Oncology
      • 7.2.4. Others (Respiratory and Orthopedic)
    • 7.3. Market Analysis, Insights and Forecast - by Provider
      • 7.3.1. Contract Research Organizations (CROs)
      • 7.3.2. Business Processing Outsourcing (BPO)
    • 7.4. Market Analysis, Insights and Forecast - by End User
      • 7.4.1. Pharmaceutical Companies
      • 7.4.2. Biopharmaceutical Companies
      • 7.4.3. Medical Device Companies
  8. 8. Europe Pharmacovigilance Outsourcing Market Analysis, Insights and Forecast, 2020-2032
    • 8.1. Market Analysis, Insights and Forecast - by Service
      • 8.1.1. Pre-marketing Services
        • 8.1.1.1. Clinical Pharmacovigilance Services
        • 8.1.1.2. Case Processing Services
        • 8.1.1.3. Safety Data Management Services
        • 8.1.1.4. Medical Review
      • 8.1.2. Post-marketing Services
        • 8.1.2.1. Knowledge Process Outsourcing Services
        • 8.1.2.2. IT Solutions and Services
    • 8.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 8.2.1. Neurology
      • 8.2.2. Cardiology
      • 8.2.3. Oncology
      • 8.2.4. Others (Respiratory and Orthopedic)
    • 8.3. Market Analysis, Insights and Forecast - by Provider
      • 8.3.1. Contract Research Organizations (CROs)
      • 8.3.2. Business Processing Outsourcing (BPO)
    • 8.4. Market Analysis, Insights and Forecast - by End User
      • 8.4.1. Pharmaceutical Companies
      • 8.4.2. Biopharmaceutical Companies
      • 8.4.3. Medical Device Companies
  9. 9. Asia Pacific Pharmacovigilance Outsourcing Market Analysis, Insights and Forecast, 2020-2032
    • 9.1. Market Analysis, Insights and Forecast - by Service
      • 9.1.1. Pre-marketing Services
        • 9.1.1.1. Clinical Pharmacovigilance Services
        • 9.1.1.2. Case Processing Services
        • 9.1.1.3. Safety Data Management Services
        • 9.1.1.4. Medical Review
      • 9.1.2. Post-marketing Services
        • 9.1.2.1. Knowledge Process Outsourcing Services
        • 9.1.2.2. IT Solutions and Services
    • 9.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 9.2.1. Neurology
      • 9.2.2. Cardiology
      • 9.2.3. Oncology
      • 9.2.4. Others (Respiratory and Orthopedic)
    • 9.3. Market Analysis, Insights and Forecast - by Provider
      • 9.3.1. Contract Research Organizations (CROs)
      • 9.3.2. Business Processing Outsourcing (BPO)
    • 9.4. Market Analysis, Insights and Forecast - by End User
      • 9.4.1. Pharmaceutical Companies
      • 9.4.2. Biopharmaceutical Companies
      • 9.4.3. Medical Device Companies
  10. 10. Middle East and Africa Pharmacovigilance Outsourcing Market Analysis, Insights and Forecast, 2020-2032
    • 10.1. Market Analysis, Insights and Forecast - by Service
      • 10.1.1. Pre-marketing Services
        • 10.1.1.1. Clinical Pharmacovigilance Services
        • 10.1.1.2. Case Processing Services
        • 10.1.1.3. Safety Data Management Services
        • 10.1.1.4. Medical Review
      • 10.1.2. Post-marketing Services
        • 10.1.2.1. Knowledge Process Outsourcing Services
        • 10.1.2.2. IT Solutions and Services
    • 10.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 10.2.1. Neurology
      • 10.2.2. Cardiology
      • 10.2.3. Oncology
      • 10.2.4. Others (Respiratory and Orthopedic)
    • 10.3. Market Analysis, Insights and Forecast - by Provider
      • 10.3.1. Contract Research Organizations (CROs)
      • 10.3.2. Business Processing Outsourcing (BPO)
    • 10.4. Market Analysis, Insights and Forecast - by End User
      • 10.4.1. Pharmaceutical Companies
      • 10.4.2. Biopharmaceutical Companies
      • 10.4.3. Medical Device Companies
  11. 11. South America Pharmacovigilance Outsourcing Market Analysis, Insights and Forecast, 2020-2032
    • 11.1. Market Analysis, Insights and Forecast - by Service
      • 11.1.1. Pre-marketing Services
        • 11.1.1.1. Clinical Pharmacovigilance Services
        • 11.1.1.2. Case Processing Services
        • 11.1.1.3. Safety Data Management Services
        • 11.1.1.4. Medical Review
      • 11.1.2. Post-marketing Services
        • 11.1.2.1. Knowledge Process Outsourcing Services
        • 11.1.2.2. IT Solutions and Services
    • 11.2. Market Analysis, Insights and Forecast - by Therapeutic Area
      • 11.2.1. Neurology
      • 11.2.2. Cardiology
      • 11.2.3. Oncology
      • 11.2.4. Others (Respiratory and Orthopedic)
    • 11.3. Market Analysis, Insights and Forecast - by Provider
      • 11.3.1. Contract Research Organizations (CROs)
      • 11.3.2. Business Processing Outsourcing (BPO)
    • 11.4. Market Analysis, Insights and Forecast - by End User
      • 11.4.1. Pharmaceutical Companies
      • 11.4.2. Biopharmaceutical Companies
      • 11.4.3. Medical Device Companies
  12. 12. Competitive Analysis
      • 12.1. Company Profiles
        • 12.1.1 Accenture
          • 12.1.1.1. Company Overview
          • 12.1.1.2. Products
          • 12.1.1.3. Company Financials
          • 12.1.1.4. SWOT Analysis
        • 12.1.2 Qinecsa Solutions
          • 12.1.2.1. Company Overview
          • 12.1.2.2. Products
          • 12.1.2.3. Company Financials
          • 12.1.2.4. SWOT Analysis
        • 12.1.3 ICON PLC
          • 12.1.3.1. Company Overview
          • 12.1.3.2. Products
          • 12.1.3.3. Company Financials
          • 12.1.3.4. SWOT Analysis
        • 12.1.4 Cognizant
          • 12.1.4.1. Company Overview
          • 12.1.4.2. Products
          • 12.1.4.3. Company Financials
          • 12.1.4.4. SWOT Analysis
        • 12.1.5 Genpact
          • 12.1.5.1. Company Overview
          • 12.1.5.2. Products
          • 12.1.5.3. Company Financials
          • 12.1.5.4. SWOT Analysis
        • 12.1.6 Infosys Limited
          • 12.1.6.1. Company Overview
          • 12.1.6.2. Products
          • 12.1.6.3. Company Financials
          • 12.1.6.4. SWOT Analysis
        • 12.1.7 TATA Consultancy Services Limited
          • 12.1.7.1. Company Overview
          • 12.1.7.2. Products
          • 12.1.7.3. Company Financials
          • 12.1.7.4. SWOT Analysis
        • 12.1.8 Oracle
          • 12.1.8.1. Company Overview
          • 12.1.8.2. Products
          • 12.1.8.3. Company Financials
          • 12.1.8.4. SWOT Analysis
        • 12.1.9 Parexel International (MA) Corporation
          • 12.1.9.1. Company Overview
          • 12.1.9.2. Products
          • 12.1.9.3. Company Financials
          • 12.1.9.4. SWOT Analysis
        • 12.1.10 Syneos Health
          • 12.1.10.1. Company Overview
          • 12.1.10.2. Products
          • 12.1.10.3. Company Financials
          • 12.1.10.4. SWOT Analysis
        • 12.1.11 IQVIA Inc *List Not Exhaustive
          • 12.1.11.1. Company Overview
          • 12.1.11.2. Products
          • 12.1.11.3. Company Financials
          • 12.1.11.4. SWOT Analysis
      • 12.2. Market Entropy
        • 12.2.1 Company's Key Areas Served
        • 12.2.2 Recent Developments
      • 12.3. Company Market Share Analysis 2025
        • 12.3.1 Top 5 Companies Market Share Analysis
        • 12.3.2 Top 3 Companies Market Share Analysis
    • 12.4. List of Potential Customers
  13. 13. Research Methodology

    List of Figures

    1. Figure 1: Global Pharmacovigilance Outsourcing Market Revenue Breakdown (Million, %) by Region 2025 & 2033
    2. Figure 2: Global Pharmacovigilance Outsourcing Market Volume Breakdown (Billion, %) by Region 2025 & 2033
    3. Figure 3: North America Pharmacovigilance Outsourcing Market Revenue (Million), by Service 2025 & 2033
    4. Figure 4: North America Pharmacovigilance Outsourcing Market Volume (Billion), by Service 2025 & 2033
    5. Figure 5: North America Pharmacovigilance Outsourcing Market Revenue Share (%), by Service 2025 & 2033
    6. Figure 6: North America Pharmacovigilance Outsourcing Market Volume Share (%), by Service 2025 & 2033
    7. Figure 7: North America Pharmacovigilance Outsourcing Market Revenue (Million), by Therapeutic Area 2025 & 2033
    8. Figure 8: North America Pharmacovigilance Outsourcing Market Volume (Billion), by Therapeutic Area 2025 & 2033
    9. Figure 9: North America Pharmacovigilance Outsourcing Market Revenue Share (%), by Therapeutic Area 2025 & 2033
    10. Figure 10: North America Pharmacovigilance Outsourcing Market Volume Share (%), by Therapeutic Area 2025 & 2033
    11. Figure 11: North America Pharmacovigilance Outsourcing Market Revenue (Million), by Provider 2025 & 2033
    12. Figure 12: North America Pharmacovigilance Outsourcing Market Volume (Billion), by Provider 2025 & 2033
    13. Figure 13: North America Pharmacovigilance Outsourcing Market Revenue Share (%), by Provider 2025 & 2033
    14. Figure 14: North America Pharmacovigilance Outsourcing Market Volume Share (%), by Provider 2025 & 2033
    15. Figure 15: North America Pharmacovigilance Outsourcing Market Revenue (Million), by End User 2025 & 2033
    16. Figure 16: North America Pharmacovigilance Outsourcing Market Volume (Billion), by End User 2025 & 2033
    17. Figure 17: North America Pharmacovigilance Outsourcing Market Revenue Share (%), by End User 2025 & 2033
    18. Figure 18: North America Pharmacovigilance Outsourcing Market Volume Share (%), by End User 2025 & 2033
    19. Figure 19: North America Pharmacovigilance Outsourcing Market Revenue (Million), by Country 2025 & 2033
    20. Figure 20: North America Pharmacovigilance Outsourcing Market Volume (Billion), by Country 2025 & 2033
    21. Figure 21: North America Pharmacovigilance Outsourcing Market Revenue Share (%), by Country 2025 & 2033
    22. Figure 22: North America Pharmacovigilance Outsourcing Market Volume Share (%), by Country 2025 & 2033
    23. Figure 23: Europe Pharmacovigilance Outsourcing Market Revenue (Million), by Service 2025 & 2033
    24. Figure 24: Europe Pharmacovigilance Outsourcing Market Volume (Billion), by Service 2025 & 2033
    25. Figure 25: Europe Pharmacovigilance Outsourcing Market Revenue Share (%), by Service 2025 & 2033
    26. Figure 26: Europe Pharmacovigilance Outsourcing Market Volume Share (%), by Service 2025 & 2033
    27. Figure 27: Europe Pharmacovigilance Outsourcing Market Revenue (Million), by Therapeutic Area 2025 & 2033
    28. Figure 28: Europe Pharmacovigilance Outsourcing Market Volume (Billion), by Therapeutic Area 2025 & 2033
    29. Figure 29: Europe Pharmacovigilance Outsourcing Market Revenue Share (%), by Therapeutic Area 2025 & 2033
    30. Figure 30: Europe Pharmacovigilance Outsourcing Market Volume Share (%), by Therapeutic Area 2025 & 2033
    31. Figure 31: Europe Pharmacovigilance Outsourcing Market Revenue (Million), by Provider 2025 & 2033
    32. Figure 32: Europe Pharmacovigilance Outsourcing Market Volume (Billion), by Provider 2025 & 2033
    33. Figure 33: Europe Pharmacovigilance Outsourcing Market Revenue Share (%), by Provider 2025 & 2033
    34. Figure 34: Europe Pharmacovigilance Outsourcing Market Volume Share (%), by Provider 2025 & 2033
    35. Figure 35: Europe Pharmacovigilance Outsourcing Market Revenue (Million), by End User 2025 & 2033
    36. Figure 36: Europe Pharmacovigilance Outsourcing Market Volume (Billion), by End User 2025 & 2033
    37. Figure 37: Europe Pharmacovigilance Outsourcing Market Revenue Share (%), by End User 2025 & 2033
    38. Figure 38: Europe Pharmacovigilance Outsourcing Market Volume Share (%), by End User 2025 & 2033
    39. Figure 39: Europe Pharmacovigilance Outsourcing Market Revenue (Million), by Country 2025 & 2033
    40. Figure 40: Europe Pharmacovigilance Outsourcing Market Volume (Billion), by Country 2025 & 2033
    41. Figure 41: Europe Pharmacovigilance Outsourcing Market Revenue Share (%), by Country 2025 & 2033
    42. Figure 42: Europe Pharmacovigilance Outsourcing Market Volume Share (%), by Country 2025 & 2033
    43. Figure 43: Asia Pacific Pharmacovigilance Outsourcing Market Revenue (Million), by Service 2025 & 2033
    44. Figure 44: Asia Pacific Pharmacovigilance Outsourcing Market Volume (Billion), by Service 2025 & 2033
    45. Figure 45: Asia Pacific Pharmacovigilance Outsourcing Market Revenue Share (%), by Service 2025 & 2033
    46. Figure 46: Asia Pacific Pharmacovigilance Outsourcing Market Volume Share (%), by Service 2025 & 2033
    47. Figure 47: Asia Pacific Pharmacovigilance Outsourcing Market Revenue (Million), by Therapeutic Area 2025 & 2033
    48. Figure 48: Asia Pacific Pharmacovigilance Outsourcing Market Volume (Billion), by Therapeutic Area 2025 & 2033
    49. Figure 49: Asia Pacific Pharmacovigilance Outsourcing Market Revenue Share (%), by Therapeutic Area 2025 & 2033
    50. Figure 50: Asia Pacific Pharmacovigilance Outsourcing Market Volume Share (%), by Therapeutic Area 2025 & 2033
    51. Figure 51: Asia Pacific Pharmacovigilance Outsourcing Market Revenue (Million), by Provider 2025 & 2033
    52. Figure 52: Asia Pacific Pharmacovigilance Outsourcing Market Volume (Billion), by Provider 2025 & 2033
    53. Figure 53: Asia Pacific Pharmacovigilance Outsourcing Market Revenue Share (%), by Provider 2025 & 2033
    54. Figure 54: Asia Pacific Pharmacovigilance Outsourcing Market Volume Share (%), by Provider 2025 & 2033
    55. Figure 55: Asia Pacific Pharmacovigilance Outsourcing Market Revenue (Million), by End User 2025 & 2033
    56. Figure 56: Asia Pacific Pharmacovigilance Outsourcing Market Volume (Billion), by End User 2025 & 2033
    57. Figure 57: Asia Pacific Pharmacovigilance Outsourcing Market Revenue Share (%), by End User 2025 & 2033
    58. Figure 58: Asia Pacific Pharmacovigilance Outsourcing Market Volume Share (%), by End User 2025 & 2033
    59. Figure 59: Asia Pacific Pharmacovigilance Outsourcing Market Revenue (Million), by Country 2025 & 2033
    60. Figure 60: Asia Pacific Pharmacovigilance Outsourcing Market Volume (Billion), by Country 2025 & 2033
    61. Figure 61: Asia Pacific Pharmacovigilance Outsourcing Market Revenue Share (%), by Country 2025 & 2033
    62. Figure 62: Asia Pacific Pharmacovigilance Outsourcing Market Volume Share (%), by Country 2025 & 2033
    63. Figure 63: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue (Million), by Service 2025 & 2033
    64. Figure 64: Middle East and Africa Pharmacovigilance Outsourcing Market Volume (Billion), by Service 2025 & 2033
    65. Figure 65: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue Share (%), by Service 2025 & 2033
    66. Figure 66: Middle East and Africa Pharmacovigilance Outsourcing Market Volume Share (%), by Service 2025 & 2033
    67. Figure 67: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue (Million), by Therapeutic Area 2025 & 2033
    68. Figure 68: Middle East and Africa Pharmacovigilance Outsourcing Market Volume (Billion), by Therapeutic Area 2025 & 2033
    69. Figure 69: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue Share (%), by Therapeutic Area 2025 & 2033
    70. Figure 70: Middle East and Africa Pharmacovigilance Outsourcing Market Volume Share (%), by Therapeutic Area 2025 & 2033
    71. Figure 71: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue (Million), by Provider 2025 & 2033
    72. Figure 72: Middle East and Africa Pharmacovigilance Outsourcing Market Volume (Billion), by Provider 2025 & 2033
    73. Figure 73: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue Share (%), by Provider 2025 & 2033
    74. Figure 74: Middle East and Africa Pharmacovigilance Outsourcing Market Volume Share (%), by Provider 2025 & 2033
    75. Figure 75: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue (Million), by End User 2025 & 2033
    76. Figure 76: Middle East and Africa Pharmacovigilance Outsourcing Market Volume (Billion), by End User 2025 & 2033
    77. Figure 77: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue Share (%), by End User 2025 & 2033
    78. Figure 78: Middle East and Africa Pharmacovigilance Outsourcing Market Volume Share (%), by End User 2025 & 2033
    79. Figure 79: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue (Million), by Country 2025 & 2033
    80. Figure 80: Middle East and Africa Pharmacovigilance Outsourcing Market Volume (Billion), by Country 2025 & 2033
    81. Figure 81: Middle East and Africa Pharmacovigilance Outsourcing Market Revenue Share (%), by Country 2025 & 2033
    82. Figure 82: Middle East and Africa Pharmacovigilance Outsourcing Market Volume Share (%), by Country 2025 & 2033
    83. Figure 83: South America Pharmacovigilance Outsourcing Market Revenue (Million), by Service 2025 & 2033
    84. Figure 84: South America Pharmacovigilance Outsourcing Market Volume (Billion), by Service 2025 & 2033
    85. Figure 85: South America Pharmacovigilance Outsourcing Market Revenue Share (%), by Service 2025 & 2033
    86. Figure 86: South America Pharmacovigilance Outsourcing Market Volume Share (%), by Service 2025 & 2033
    87. Figure 87: South America Pharmacovigilance Outsourcing Market Revenue (Million), by Therapeutic Area 2025 & 2033
    88. Figure 88: South America Pharmacovigilance Outsourcing Market Volume (Billion), by Therapeutic Area 2025 & 2033
    89. Figure 89: South America Pharmacovigilance Outsourcing Market Revenue Share (%), by Therapeutic Area 2025 & 2033
    90. Figure 90: South America Pharmacovigilance Outsourcing Market Volume Share (%), by Therapeutic Area 2025 & 2033
    91. Figure 91: South America Pharmacovigilance Outsourcing Market Revenue (Million), by Provider 2025 & 2033
    92. Figure 92: South America Pharmacovigilance Outsourcing Market Volume (Billion), by Provider 2025 & 2033
    93. Figure 93: South America Pharmacovigilance Outsourcing Market Revenue Share (%), by Provider 2025 & 2033
    94. Figure 94: South America Pharmacovigilance Outsourcing Market Volume Share (%), by Provider 2025 & 2033
    95. Figure 95: South America Pharmacovigilance Outsourcing Market Revenue (Million), by End User 2025 & 2033
    96. Figure 96: South America Pharmacovigilance Outsourcing Market Volume (Billion), by End User 2025 & 2033
    97. Figure 97: South America Pharmacovigilance Outsourcing Market Revenue Share (%), by End User 2025 & 2033
    98. Figure 98: South America Pharmacovigilance Outsourcing Market Volume Share (%), by End User 2025 & 2033
    99. Figure 99: South America Pharmacovigilance Outsourcing Market Revenue (Million), by Country 2025 & 2033
    100. Figure 100: South America Pharmacovigilance Outsourcing Market Volume (Billion), by Country 2025 & 2033
    101. Figure 101: South America Pharmacovigilance Outsourcing Market Revenue Share (%), by Country 2025 & 2033
    102. Figure 102: South America Pharmacovigilance Outsourcing Market Volume Share (%), by Country 2025 & 2033

    List of Tables

    1. Table 1: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Service 2020 & 2033
    2. Table 2: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Service 2020 & 2033
    3. Table 3: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Therapeutic Area 2020 & 2033
    4. Table 4: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Therapeutic Area 2020 & 2033
    5. Table 5: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Provider 2020 & 2033
    6. Table 6: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Provider 2020 & 2033
    7. Table 7: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by End User 2020 & 2033
    8. Table 8: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by End User 2020 & 2033
    9. Table 9: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Region 2020 & 2033
    10. Table 10: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Region 2020 & 2033
    11. Table 11: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Service 2020 & 2033
    12. Table 12: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Service 2020 & 2033
    13. Table 13: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Therapeutic Area 2020 & 2033
    14. Table 14: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Therapeutic Area 2020 & 2033
    15. Table 15: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Provider 2020 & 2033
    16. Table 16: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Provider 2020 & 2033
    17. Table 17: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by End User 2020 & 2033
    18. Table 18: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by End User 2020 & 2033
    19. Table 19: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Country 2020 & 2033
    20. Table 20: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Country 2020 & 2033
    21. Table 21: United States Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    22. Table 22: United States Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    23. Table 23: Canada Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    24. Table 24: Canada Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    25. Table 25: Mexico Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    26. Table 26: Mexico Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    27. Table 27: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Service 2020 & 2033
    28. Table 28: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Service 2020 & 2033
    29. Table 29: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Therapeutic Area 2020 & 2033
    30. Table 30: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Therapeutic Area 2020 & 2033
    31. Table 31: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Provider 2020 & 2033
    32. Table 32: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Provider 2020 & 2033
    33. Table 33: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by End User 2020 & 2033
    34. Table 34: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by End User 2020 & 2033
    35. Table 35: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Country 2020 & 2033
    36. Table 36: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Country 2020 & 2033
    37. Table 37: Germany Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    38. Table 38: Germany Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    39. Table 39: United Kingdom Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    40. Table 40: United Kingdom Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    41. Table 41: France Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    42. Table 42: France Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    43. Table 43: Italy Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    44. Table 44: Italy Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    45. Table 45: Spain Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    46. Table 46: Spain Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    47. Table 47: Rest of Europe Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    48. Table 48: Rest of Europe Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    49. Table 49: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Service 2020 & 2033
    50. Table 50: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Service 2020 & 2033
    51. Table 51: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Therapeutic Area 2020 & 2033
    52. Table 52: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Therapeutic Area 2020 & 2033
    53. Table 53: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Provider 2020 & 2033
    54. Table 54: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Provider 2020 & 2033
    55. Table 55: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by End User 2020 & 2033
    56. Table 56: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by End User 2020 & 2033
    57. Table 57: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Country 2020 & 2033
    58. Table 58: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Country 2020 & 2033
    59. Table 59: China Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    60. Table 60: China Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    61. Table 61: Japan Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    62. Table 62: Japan Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    63. Table 63: India Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    64. Table 64: India Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    65. Table 65: Australia Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    66. Table 66: Australia Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    67. Table 67: South Korea Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    68. Table 68: South Korea Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    69. Table 69: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    70. Table 70: Rest of Asia Pacific Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    71. Table 71: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Service 2020 & 2033
    72. Table 72: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Service 2020 & 2033
    73. Table 73: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Therapeutic Area 2020 & 2033
    74. Table 74: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Therapeutic Area 2020 & 2033
    75. Table 75: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Provider 2020 & 2033
    76. Table 76: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Provider 2020 & 2033
    77. Table 77: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by End User 2020 & 2033
    78. Table 78: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by End User 2020 & 2033
    79. Table 79: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Country 2020 & 2033
    80. Table 80: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Country 2020 & 2033
    81. Table 81: GCC Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    82. Table 82: GCC Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    83. Table 83: South Africa Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    84. Table 84: South Africa Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    85. Table 85: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    86. Table 86: Rest of Middle East and Africa Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    87. Table 87: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Service 2020 & 2033
    88. Table 88: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Service 2020 & 2033
    89. Table 89: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Therapeutic Area 2020 & 2033
    90. Table 90: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Therapeutic Area 2020 & 2033
    91. Table 91: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Provider 2020 & 2033
    92. Table 92: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Provider 2020 & 2033
    93. Table 93: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by End User 2020 & 2033
    94. Table 94: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by End User 2020 & 2033
    95. Table 95: Global Pharmacovigilance Outsourcing Market Revenue Million Forecast, by Country 2020 & 2033
    96. Table 96: Global Pharmacovigilance Outsourcing Market Volume Billion Forecast, by Country 2020 & 2033
    97. Table 97: Brazil Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    98. Table 98: Brazil Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    99. Table 99: Argentina Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    100. Table 100: Argentina Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033
    101. Table 101: Rest of South America Pharmacovigilance Outsourcing Market Revenue (Million) Forecast, by Application 2020 & 2033
    102. Table 102: Rest of South America Pharmacovigilance Outsourcing Market Volume (Billion) Forecast, by Application 2020 & 2033

    Frequently Asked Questions

    1. What is the projected Compound Annual Growth Rate (CAGR) of the Pharmacovigilance Outsourcing Market?

    The projected CAGR is approximately 15.80%.

    2. Which companies are prominent players in the Pharmacovigilance Outsourcing Market?

    Key companies in the market include Accenture, Qinecsa Solutions, ICON PLC, Cognizant, Genpact, Infosys Limited, TATA Consultancy Services Limited, Oracle, Parexel International (MA) Corporation, Syneos Health, IQVIA Inc *List Not Exhaustive.

    3. What are the main segments of the Pharmacovigilance Outsourcing Market?

    The market segments include Service, Therapeutic Area, Provider, End User.

    4. Can you provide details about the market size?

    The market size is estimated to be USD 6.84 Million as of 2022.

    5. What are some drivers contributing to market growth?

    Growing High Profile Drug Recalls due to Safety Concerns; Rising Incidence of Adverse Drug Reactions (ADRs).

    6. What are the notable trends driving market growth?

    The Oncology Segment is Expected to Hold Significant Market Share During the Forecast Period.

    7. Are there any restraints impacting market growth?

    Growing High Profile Drug Recalls due to Safety Concerns; Rising Incidence of Adverse Drug Reactions (ADRs).

    8. Can you provide examples of recent developments in the market?

    July 2024: Oracle reported significant updates to its Argus and Safety One Intake solutions, bolstering its pharmacovigilance portfolio with AI-powered features. These AI enhancements cater to the evolving needs of life science organizations, allowing them to navigate increasingly complex regulatory landscapes and manage rising adverse event cases efficiently.

    9. What pricing options are available for accessing the report?

    Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.

    10. Is the market size provided in terms of value or volume?

    The market size is provided in terms of value, measured in Million and volume, measured in Billion.

    11. Are there any specific market keywords associated with the report?

    Yes, the market keyword associated with the report is "Pharmacovigilance Outsourcing Market," which aids in identifying and referencing the specific market segment covered.

    12. How do I determine which pricing option suits my needs best?

    The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

    13. Are there any additional resources or data provided in the Pharmacovigilance Outsourcing Market report?

    While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

    14. How can I stay updated on further developments or reports in the Pharmacovigilance Outsourcing Market?

    To stay informed about further developments, trends, and reports in the Pharmacovigilance Outsourcing Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

    Methodology

    Step 1 - Identification of Relevant Samples Size from Population Database

    Step Chart
    Bar Chart
    Method Chart

    Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

    Approach Chart
    Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

    Note*: In applicable scenarios

    Step 3 - Data Sources

    Primary Research

    • Web Analytics
    • Survey Reports
    • Research Institute
    • Latest Research Reports
    • Opinion Leaders

    Secondary Research

    • Annual Reports
    • White Paper
    • Latest Press Release
    • Industry Association
    • Paid Database
    • Investor Presentations
    Analyst Chart

    Step 4 - Data Triangulation

    Involves using different sources of information in order to increase the validity of a study

    These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

    Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

    During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

    Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.